Showing results (191-200 of 315) with videos related to

Sort By:
Pageof 32
The Journal of Clinical Endocrinology and Metabolism|April 1, 1996
Putative melatonin receptors in benign human prostate tissueM Laudon, E Gilad, H Matzkin, et al.
Urology|July 1, 1996
Effect of elective prolonged urethral catheterization on serum prostate-specific antigen concentrationH Matzkin, M Laufer, J Chen, et al.
American Journal of Clinical Pathology|March 1, 1986
Osteogenic differentiation associated with x-ray therapy for adenocarcinoma of the prostate glandJ R Locke, M S Soloway, J Evans, et al.
Urology|June 7, 2000
Signet ring cell carcinoma of a pulled-through sigmoid colon mimicking a primary invasive bladder tumor: case report and review of the literatureJ T Posey, E Z Neulander, M S Soloway, et al.
Urology|September 4, 1999
Age as a prognostic factor for disease recurrence after radical prostatectomyC Obek, S Lai, S Sadek, et al.
The Journal of Urology|April 1, 1975
Failure of ascorbic acid to inhibit FANFT-induced bladder cancerM S Soloway, S M Cohen, J B Dekernion, et al.
The Journal of Urology|June 1, 1980
Malignant fibrous histiocytoma of the kidneyN V Raghavaiah, R F Mayer, R Hagitt, et al.
Urology|March 1, 1997
Fibroepithelial polyp of the renal pelvis: nephron-sparing surgery after false-positive biopsy for transitional cell carcinomaJ D Brady, H J Korman, F Civantos, et al.
Cancer Research|February 1, 1980
Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasmsY Daskal, M S Soloway, M D DeFuria, et al.
The Journal of Urology|May 1, 1989
Prognostic factors in survival free of progression after androgen deprivation therapy for treatment of prostate cancerS Ishikawa, M S Soloway, R Van der Zwaag, et al.
Pageof 32